Abstract
1. A comparison of some cardiovascular effects of propranolol, MJ 1999 and quinidine has been made in rats and dogs.
2. After intravenous, subcutaneous or oral administration to rats and dogs, propranolol was found to be 2-4 times more potent than MJ 1999 in blocking the chronotropic and vasodepressor responses to intravenously administered isoprenaline.
3. Propranolol and quinidine affected the e.c.g. of rats and dogs in a similar manner.
4. At dose-levels causing effective blockade of β-receptors propranolol and MJ 1999 had no hypotensive effect after short- or long-term administration to conscious hypertensive rats and dogs.
5. At very high dose-levels propranolol and quinidine, but not MJ 1999, lowered blood pressure in the hypertensive rat. This effect of propranolol is probably related to one or more of the properties that propranolol and quinidine have in common rather than to a blockade of β-receptors.
6. The possible relevance of these results to the use of propranolol as a hypotensive agent in man is discussed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cullum V. A., Farmer J. B., Handley S. L. The antihypertensive properties of 1-amino-4-phenyl pyridinium chloride. Br J Pharmacol Chemother. 1967 Nov;31(3):435–446. doi: 10.1111/j.1476-5381.1967.tb00410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Howe R., Shanks R. G. Optical isomers of propranolol. Nature. 1966 Jun 25;210(5043):1336–1338. doi: 10.1038/2101336a0. [DOI] [PubMed] [Google Scholar]
- LYON A. F., DEGRAFF A. C. ANTIARRHYTHMIC DRUGS. I. MECHANISM OF QUINIDINE ACTION. Am Heart J. 1965 May;69:713–715. doi: 10.1016/0002-8703(65)90255-3. [DOI] [PubMed] [Google Scholar]
- Lish P. M., Weikel J. H., Dungan K. W. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. J Pharmacol Exp Ther. 1965 Aug;149(2):161–173. [PubMed] [Google Scholar]
- Lucchesi B. R., Whitsitt L. S., Stickney J. L. Antiarrhythmic effects of beta adrenergic blocking agents. Ann N Y Acad Sci. 1967 Feb 10;139(3):940–951. doi: 10.1111/j.1749-6632.1967.tb41262.x. [DOI] [PubMed] [Google Scholar]
- Moran N. C. The development of beta adrenergic blocking drugs: a retrospective and prospective evaluation. Ann N Y Acad Sci. 1967 Feb 10;139(3):649–660. doi: 10.1111/j.1749-6632.1967.tb41235.x. [DOI] [PubMed] [Google Scholar]
- PRICHARD B. N., GILLAM P. M. USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION. Br Med J. 1964 Sep 19;2(5411):725–727. doi: 10.1136/bmj.2.5411.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Paterson J. W., Dollery C. T. Effect of propranolol in mild hypertension. Lancet. 1966 Nov 26;2(7474):1148–1150. doi: 10.1016/s0140-6736(66)90471-5. [DOI] [PubMed] [Google Scholar]
- Prichard B. N., Gillam P. M. Propranolol in hypertension. Am J Cardiol. 1966 Sep;18(3):387–393. doi: 10.1016/0002-9149(66)90059-2. [DOI] [PubMed] [Google Scholar]
- Richards F. A. Propranolol in hypertension. Am J Cardiol. 1966 Sep;18(3):384–386. doi: 10.1016/0002-9149(66)90058-0. [DOI] [PubMed] [Google Scholar]
- Shanks R. G. The peripheral vascular effects of propranolol and related compounds. Br J Pharmacol Chemother. 1967 Feb;29(2):204–217. doi: 10.1111/j.1476-5381.1967.tb01953.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson R. H., Letley E. What is a beta-blocker? Lancet. 1967 Nov 25;2(7526):1149–1149. doi: 10.1016/s0140-6736(67)90656-3. [DOI] [PubMed] [Google Scholar]
- Waal H. J. Hypotensive action of propranolol. Clin Pharmacol Ther. 1966 Sep-Oct;7(5):588–598. doi: 10.1002/cpt196675588. [DOI] [PubMed] [Google Scholar]